Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single Supply Disruption — Fresenius Kabi USA, LLC (Low
Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single Supply Disruption — Fresenius Kabi USA, LLC (Low is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single; Manufacturer: Fresen
| Drug name | Hydralazine Hydrochloride Injection, USP, 20 mg/mL, 1 mL fill, in a 2 mL; single |
|---|---|
| Manufacturer | Fresenius Kabi USA, LLC |
| Recall/Disruption reason | Incorrect Expiration Date: The "11/06" expiration date printed on the tray (secondary packaging) is incorrect (it should |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1327-2015 |
| Initiation date | 20150728 |
| Quantity affected | 93,000 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →